NGM Biopharmaceuticals, Inc. documents

Explore the latest documents from NGM Biopharmaceuticals, Inc., including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.

Description

Event date

Documents and forms

2024

Corporate Presentation

Jan 9, 2024

Slides

2023

Q4 2023

Mar 11, 2024

Annual report10-K

Earnings release8-K

Q3 2023

Nov 2, 2023

Quarterly report10-Q

Earnings release8-K

Q2 2023

Aug 2, 2023

Quarterly report10-Q

Earnings release8-K

Q1 2023

May 4, 2023

Quarterly report10-Q

Earnings release8-K

2022

Q4 2022

Feb 28, 2023

Annual report10-K

Earnings release8-K

Q3 2022

Nov 3, 2022

Quarterly report10-Q

Earnings release8-K

Study Result

Oct 17, 2022

Slides

Press release

Q2 2022

Aug 4, 2022

Quarterly report10-Q

Earnings release8-K

Status Update

Jun 29, 2022

Slides

Status Update

May 31, 2022

Slides

Q1 2022

May 5, 2022

Quarterly report10-Q

Earnings release8-K

Status Update

Mar 30, 2022

Slides

JPMorgan 40th Annual Healthcare Conference

Jan 13, 2022

Slides

2021

Q4 2021

Mar 1, 2022

Annual report10-K

Earnings release8-K

Q3 2021

Nov 4, 2021

Quarterly report10-Q

Earnings release8-K

Q2 2021

Aug 5, 2021

Quarterly report10-Q

Earnings release8-K

Study Result

May 24, 2021

Press release

Slides

Q1 2021

May 6, 2021

Quarterly report10-Q

Earnings release8-K

2020

Q4 2020

Mar 4, 2021

Annual report10-K

Earnings release8-K

R&D Day 2020

Dec 9, 2020

Press release

Slides

Q3 2020

Nov 12, 2020

Quarterly report10-Q

Earnings release8-K

Q2 2020

Aug 12, 2020

Quarterly report10-Q

Earnings release8-K

Q1 2020

May 13, 2020

Quarterly report10-Q

Earnings release8-K

2019

Q4 2019

Mar 17, 2020

Annual report10-K

Earnings release8-K

Q3 2019

Nov 12, 2019

Quarterly report10-Q

Earnings release8-K

Q2 2019

Aug 12, 2019

Quarterly report10-Q

Earnings release8-K

Q1 2019

May 16, 2019

Quarterly report10-Q

Earnings release8-K